Publications by authors named "Karen S King"

10Publications

Accurate interrogation of FCGR3A rs396991 in European and Asian populations using a widely available TaqMan genotyping method.

Pharmacogenet Genomics 2015 Nov;25(11):569-72

aGenetics bBiopharm Discovery, GlaxoSmithKline, Stevenage, UK cGenetics, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.

View Article and Find Full Text PDF
November 2015

Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.

Pharmacogenomics 2015 12;16(11):1227-9. Epub 2015 Aug 12.

GlaxoSmithKline Research & Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.

View Article and Find Full Text PDF
June 2016

HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.

J Clin Oncol 2011 Feb 18;29(6):667-73. Epub 2011 Jan 18.

GlaxoSmithKline Research and Development, Genetics Division, Medicines Development Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NF, United Kingdom.

View Article and Find Full Text PDF
February 2011

Genes mirror geography within Europe.

Nature 2008 Nov 31;456(7218):98-101. Epub 2008 Aug 31.

Department of Ecology and Evolutionary Biology, Interdepartmental Program in Bioinformatics, University of California-Los Angeles, Los Angeles, California 90095, USA.

View Article and Find Full Text PDF
November 2008